Market Closed -
Nyse
04:00:02 2024-05-15 pm EDT
|
5-day change
|
1st Jan Change
|
30.16
USD
|
+0.73%
|
|
-2.14%
|
+39.24%
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
12,939
|
13,637
|
18,447
|
-
|
-
|
Enterprise Value (EV)
1 |
23,313
|
20,561
|
27,815
|
27,815
|
27,815
|
P/E ratio
|
1.59
x
|
12.7
x
|
5.98
x
|
5.29
x
|
4.6
x
|
Yield
|
2.29%
|
12.5%
|
3.17%
|
3.99%
|
3.88%
|
Capitalization / Revenue
|
0.72
x
|
0.64
x
|
0.78
x
|
0.74
x
|
0.71
x
|
EV / Revenue
|
1.29
x
|
0.97
x
|
1.18
x
|
1.12
x
|
1.07
x
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
-
|
EV / FCF
|
-
|
-
|
15.5
x
|
13.9
x
|
-
|
FCF Yield
|
-
|
-
|
6.47%
|
7.19%
|
-
|
Price to Book
|
1.58
x
|
1.14
x
|
1.38
x
|
1.15
x
|
0.91
x
|
Nbr of stocks (in thousands)
|
645,000
|
629,596
|
611,641
|
-
|
-
|
Reference price
2 |
20.06
|
21.66
|
30.16
|
30.16
|
30.16
|
Announcement Date
|
2/17/23
|
2/15/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
18,056
|
21,212
|
23,511
|
24,802
|
25,888
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
2,544
|
3,125
|
4,131
|
4,485
|
4,461
|
Operating Margin
|
14.09%
|
14.73%
|
17.57%
|
18.08%
|
17.23%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
4,064
|
4,272
|
Net income
1 |
8,149
|
1,104
|
3,039
|
3,149
|
3,320
|
Net margin
|
45.13%
|
5.2%
|
12.92%
|
12.7%
|
12.82%
|
EPS
2 |
12.59
|
1.710
|
5.045
|
5.696
|
6.557
|
Free Cash Flow
1 |
-
|
-
|
1,800
|
2,000
|
-
|
FCF margin
|
-
|
-
|
7.66%
|
8.06%
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
59.24%
|
63.51%
|
-
|
Dividend per Share
2 |
0.4600
|
2.700
|
0.9571
|
1.204
|
1.170
|
Announcement Date
|
2/17/23
|
2/15/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
4,441
|
5,369
|
5,363
|
5,845
|
4,081
|
5,923
|
5,853
|
5,809
|
5,888
|
6,104
|
6,173
|
6,289
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
549
|
706
|
-
|
945
|
909
|
798
|
786
|
1,069
|
1,122
|
1,155
|
-
|
-
|
Operating Margin
|
12.36%
|
13.15%
|
-
|
16.17%
|
22.27%
|
13.47%
|
13.43%
|
18.4%
|
19.06%
|
18.92%
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
2,351
|
-566
|
-459
|
771
|
2,101
|
-1,309
|
878
|
692.6
|
739.9
|
746
|
751
|
769.5
|
Net margin
|
52.94%
|
-10.54%
|
-8.56%
|
13.19%
|
51.48%
|
-22.1%
|
15%
|
11.92%
|
12.57%
|
12.22%
|
12.17%
|
12.24%
|
EPS
2 |
3.630
|
-0.8700
|
-0.7000
|
1.180
|
3.280
|
-2.070
|
1.410
|
1.132
|
1.250
|
1.296
|
1.356
|
1.393
|
Dividend per Share
2 |
0.2300
|
0.2300
|
0.2300
|
0.2300
|
0.2300
|
1.390
|
0.2300
|
0.2317
|
0.2419
|
0.2567
|
0.2600
|
0.2591
|
Announcement Date
|
11/9/22
|
2/17/23
|
5/9/23
|
8/4/23
|
11/3/23
|
2/15/24
|
5/3/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
10,374
|
6,924
|
9,368
|
9,368
|
9,368
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
1,800
|
2,000
|
-
|
ROE (net income / shareholders' equity)
|
9.1%
|
11.3%
|
12.3%
|
13%
|
13.1%
|
ROA (Net income/ Total Assets)
|
2.09%
|
-
|
25%
|
26.9%
|
-
|
Assets
1 |
390,222
|
-
|
12,168
|
11,685
|
-
|
Book Value Per Share
2 |
12.70
|
18.90
|
21.90
|
26.30
|
33.30
|
Cash Flow per Share
|
4.160
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/17/23
|
2/15/24
|
-
|
-
|
-
|
Last Close Price
30.16
USD Average target price
31.33
USD Spread / Average Target +3.89% Consensus |
1st Jan change
|
Capi.
|
---|
| +39.24% | 18.31B | | +13.16% | 79.54B | | +10.59% | 52.13B | | +6.04% | 49.04B | | +21.41% | 46.7B | | +15.32% | 42.69B | | +28.76% | 41.44B | | +0.65% | 29.51B | | -3.35% | 29.11B | | -9.40% | 27.32B |
Other Life & Health Insurance
|